These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22893256)

  • 41. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug.
    Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS
    Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterisation of solid dispersions of paracetamol and EUDRAGIT E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis.
    Qi S; Gryczke A; Belton P; Craig DQ
    Int J Pharm; 2008 Apr; 354(1-2):158-67. PubMed ID: 18242020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Injection Molding and its application to drug delivery.
    Zema L; Loreti G; Melocchi A; Maroni A; Gazzaniga A
    J Control Release; 2012 May; 159(3):324-31. PubMed ID: 22245483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M; Peppas NA; McGinity JW
    J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melt extrusion: process to product.
    Repka MA; Shah S; Lu J; Maddineni S; Morott J; Patwardhan K; Mohammed NN
    Expert Opin Drug Deliv; 2012 Jan; 9(1):105-25. PubMed ID: 22145932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release.
    Kyobula M; Adedeji A; Alexander MR; Saleh E; Wildman R; Ashcroft I; Gellert PR; Roberts CJ
    J Control Release; 2017 Sep; 261():207-215. PubMed ID: 28668378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
    Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
    Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-extruded solid solutions as immediate release fixed-dose combinations.
    Dierickx L; Van Snick B; Monteyne T; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2014 Oct; 88(2):502-9. PubMed ID: 25008213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hot-melt extrusion.
    Jana S; Miloslava R
    Ceska Slov Farm; 2012 Jun; 61(3):87-92. PubMed ID: 22913823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of acetaminophen's solubility in poly(ethylene oxide) by rheological, thermal and microscopic methods.
    Yang M; Wang P; Suwardie H; Gogos C
    Int J Pharm; 2011 Jan; 403(1-2):83-9. PubMed ID: 20974240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability.
    Zhang L; Chai G; Zeng X; He H; Xu H; Tang X
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1054-63. PubMed ID: 20818965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs.
    Van den Mooter G; Weuts I; De Ridder T; Blaton N
    Int J Pharm; 2006 Jun; 316(1-2):1-6. PubMed ID: 16563676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calendering as a direct shaping tool for the continuous production of fixed-dose combination products via co-extrusion.
    Vynckier AK; Lin H; Zeitler JA; Willart JF; Bongaers E; Voorspoels J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Oct; 96():125-31. PubMed ID: 26232550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum.
    Fukuda M; Peppas NA; McGinity JW
    Int J Pharm; 2006 Mar; 310(1-2):90-100. PubMed ID: 16413153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of the potential of amphiphilic conetworks based on poly(2-ethyl-2-oxazoline) as new platforms for delivery of drugs with limited solubility.
    Kostova B; Ivanova-Mileva K; Rachev D; Christova D
    AAPS PharmSciTech; 2013 Mar; 14(1):352-9. PubMed ID: 23325383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.